2 The development of iron chelating drugs
- 1 April 1989
- journal article
- review article
- Published by Elsevier in Bailliere's Clinical Haematology
- Vol. 2 (2), 257-292
- https://doi.org/10.1016/s0950-3536(89)80018-6
Abstract
No abstract availableKeywords
This publication has 95 references indexed in Scilit:
- A five-coordinate copper complex with superoxide dismutase mimetic activity fromStreptomyces antibioticusBioMetals, 1988
- Yersinia Sepsis in Patients with Iron Overload Treated with DeferoxamineNew England Journal of Medicine, 1986
- Non-transferrin-bound iron in long-term transfusion in children with congenital anemiasThe Journal of Pediatrics, 1986
- The study of iron mobilisation from transferrin using α-ketohydroxy heteroaromatic chelatorsBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1986
- CLINICAL TRIAL OF DESFERRIOXAMINE ENTRAPPED IN RED CELL GHOSTSThe Lancet, 1980
- THE STATUS OF NEW IRON CHELATORS*Annals of the New York Academy of Sciences, 1980
- A non-transferrin-bound serum iron in idiopathic hemochromatosisDigestive Diseases and Sciences, 1980
- Mobilization of iron from reticulocytesFEBS Letters, 1979
- Feasibility of enterochelin as an iron-chelating drug: Studies with human serum and a mouse model systemGeneral Pharmacology: The Vascular System, 1978
- Chelating Tendencies of N,N'-Ethylenebis-[2-(o-hydroxyphenyl)]-glycineJournal of the American Chemical Society, 1958